BofA raised the firm’s price target on Amphenol (APH) to $75 from $74 and keeps a Neutral rating on the shares. The firm is modeling calendar Q4 revenue and EPS above the Street view and expects “modest” Q1 guidance of $3.9B-$4.0B in revenue, the analyst tells investors in a preview.